Key Metrics of Puma Biotechnology
Revenue$236M▲ 3.3% YoYFY 2023
Operating income$32.6M▲ 37.6% YoY
Net profit$21.6M▲ 1,079,450.0% YoY
Shareholders' equity$53.4M
Market cap$544MPBYI · $10.54
Competitors10identified
About Puma Biotechnology
Sectors
Company details
- Website
- pumabiotechnology.com
- Listed
- Nasdaq: PBYI
Operational Areas of Puma Biotechnology
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal namePuma Biotechnology Inc
TickerPBYI
ExchangeNasdaq
CountryUnited States
SEC CIK0001401667
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://www.pumabiotechnology.com
US market & SEC filings
PBYI · Nasdaq · SEC CIK 0001401667
Last price · 31 Oct 2026
$10.54
−0.75%
Market cap$544M
P/E23.4On FY 2023 diluted EPS
Volume224,300
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States
PBYI share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeLos Angeles
GSTIN—
Email—
Websitehttp://www.pumabiotechnology.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Puma Biotechnology
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.